The Artelon extremities tissue implant is acquired and brought to US

By

Artelon® Product Line Under New Ownership, Relocates Operations from Sweden to U.S. (press release)
International Life Sciences, LLC (dba, Artelon®) acquired the assets of Artimplant® AB in January 2014 and has relocated operations from Sweden to the United States.  This international relocation allows Artelon® to more closely engage its largest customer base and provide additional opportunities for product development that were not previously available.
Adam Barese now serves as the Chief Executive Officer of the Organization.  After garnering almost two decades of medical industry experience...

Get access to full posts newsletters, trends, and market reports for only subscribe for $1/day.
Hit the SUBSCRIBE button at the top of the homepage.